Loxapine for schizophrenia

2007223 citationsReviewbronze Open Access

Authors

Abhijit Chakrabarti · St James's University Hospital

Anne‐Marie Bagnall · Leeds Beckett University

Pierre Chue · University of Alberta

Mark Fenton · National Institute for Health and Care Excellence

Vikram Palanisamy · Cheshire West and Chester

Winson Wong · Health Education England

Jun Xia

Abstract

Loxapine is an antipsychotic which is not clearly distinct from typical or atypical drugs in terms of its effects on global or mental state. Loxapines profile of adverse effects is similar to that of the older generation of antipsychotic drugs.

Topics & Keywords

Schizophrenia research and treatment Treatment of Major Depression Bipolar Disorder and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cochrane Database of Systematic Reviews

Volume 2015, Issue 10, pp. CD001943-CD001943

DOI: 10.1002/14651858.cd001943.pub2

Field-Weighted Citation Impact: 0.80